FK‐506–A Novel Immunosuppressant
- 1 June 1993
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 685 (1), 22-36
- https://doi.org/10.1111/j.1749-6632.1993.tb35847.x
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Local Cyclosporin-A treatment in infiltrative endocrine ophthalmopathyJournal of Autoimmunity, 1992
- Topical Cyclosportine-A in the treatment of external immunologically mediated ophthalmological diseasesJournal of Autoimmunity, 1992
- Cyclosporin (Sandimmun(R)) in chronic endogenous UveitisJournal of Autoimmunity, 1992
- Cyclosporin in the treatment of rheumatoid arthritisJournal of Autoimmunity, 1992
- Cyclosporin for severe idiopathic membranous nephropathyJournal of Autoimmunity, 1992
- Combined ciclosporin A/steroid treatment for SLE patientsJournal of Autoimmunity, 1992
- Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.Proceedings of the National Academy of Sciences, 1990
- The Effect of Cyclosporine on the Use of Hospital Resources for Kidney TransplantationNew England Journal of Medicine, 1989
- A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinNature, 1989
- Cyclosporin AJournal of the American Academy of Dermatology, 1986